Daejeon, South Korea

Ho Young Song

USPTO Granted Patents = 27 

 

 

Average Co-Inventor Count = 5.5

ph-index = 8

Forward Citations = 731(Granted Patents)


Location History:

  • Jinbuk-dong, Cheonju-si, Cheonrabuk-do, KR (1994)
  • Deajeon, KR (2023)
  • Daejeon, KR (2012 - 2024)

Company Filing History:


Years Active: 1994-2025

Loading Chart...
Loading Chart...
Loading Chart...
27 patents (USPTO):Explore Patents

Title: Innovative Contributions of Ho Young Song in Antibody-Drug Conjugates

Introduction

Ho Young Song, based in Daejeon, South Korea, is an accomplished inventor with a remarkable portfolio of 25 patents. His work primarily focuses on advancements in antibody-drug conjugates (ADCs), which are crucial in enhancing targeted drug delivery for cancer treatments.

Latest Patents

Ho Young Song's recent patents include innovative approaches to ADCs, including methods involving branched linkers. One of his significant inventions relates to ADCs in which multiple active agents are conjugated to an antibody via branched linkers. This invention allows for the coupling of two or more branched linkers to the antibody, enhancing therapeutic efficacy. Another noteworthy patent details compositions and methods related to anti-CD19 ADCs, featuring covalent linkers that connect active agents to anti-CD19 antibodies. This innovation has potential applications in various therapeutic, diagnostic, and prophylactic scenarios.

Career Highlights

Throughout his career, Ho Young Song has accumulated extensive experience in the biotechnology sector. He has worked at reputable organizations such as Legochem Biosciences, Inc. and the Electronics and Telecommunications Research Institute. His contributions have significantly impacted the development of targeted therapies.

Collaborations

In his journey as an inventor, Ho Young Song has collaborated with notable colleagues, including Yong Zu Kim and Jeiwook Chae. Their collective expertise and insights have likely fueled innovative advancements in their respective fields.

Conclusion

Ho Young Song's contributions to the field of antibody-drug conjugates underscore the importance of innovation in biomedical research. With his significant patent portfolio and collaborative spirit, he continues to forge paths toward effective therapies, reinforcing the impact of inventive minds in the healthcare industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…